US 9005599
Genetically modified human umbilical cord perivascular cells for prophylaxis against or treatment of biological or chemical agents
granted A61KA61K2035/124A61K2039/505
Quick answer
US patent 9005599 (Genetically modified human umbilical cord perivascular cells for prophylaxis against or treatment of biological or chemical agents) held by Tissue Regeneration Therapeutics Inc. expires Mon Apr 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Tissue Regeneration Therapeutics Inc.
- Grant date
- Tue Apr 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K2035/124, A61K2039/505, A61K2239/31, A61K35/44